摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-[(1E)-3-(4-methylphenyl)-3-oxo-1-propenyl]benzonitrile | 403615-46-3

中文名称
——
中文别名
——
英文名称
4-[(1E)-3-(4-methylphenyl)-3-oxo-1-propenyl]benzonitrile
英文别名
4-[(E)-3-(4-Methylphenyl)-3-oxoprop-1-en-1-yl]benzonitrile;4-[(E)-3-(4-methylphenyl)-3-oxoprop-1-enyl]benzonitrile
4-[(1E)-3-(4-methylphenyl)-3-oxo-1-propenyl]benzonitrile化学式
CAS
403615-46-3
化学式
C17H13NO
mdl
——
分子量
247.296
InChiKey
KDFIDEMXURYTFD-DHZHZOJOSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.2
  • 重原子数:
    19
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.06
  • 拓扑面积:
    40.9
  • 氢给体数:
    0
  • 氢受体数:
    2

反应信息

点击查看最新优质反应信息

文献信息

  • [EN] 2,3,5 TRISUBSTITUTED PYRROLE DERIVATIVES AS TOPOISOMERASE INHIBITORS AND THERAPEUTIC USES THEREOF<br/>[FR] DÉRIVÉS TRISUBSTITUÉS 2, 3, 5 DE PYRROLE EN TANT QU'INHIBITEURS DE TOPOISOMÉRASE ET LEURS UTILISATIONS THÉRAPEUTIQUES
    申请人:UNIV OF MYSORE
    公开号:WO2017029684A1
    公开(公告)日:2017-02-23
    The compounds of Formula (1) having topoisomerase inhibitory effect includes [Formula should be inserted here] wherein, R1 is selected from a group consisting of H, OR5, optionally substituted C1-C12 alkyl, haloalkyl, C2-C12alkenyl, C2-C12alkynyl, C1-C12alkyloxy, C1-C12haloalkyloxy, C2-C10 heteroalkyl, C3- C12 cycloalkyl, C3-C12cycloalkenyl, C2- C12heterocycloalkyl, C2-C2 heterocycloalkenyl, C6-C18aryl, and C1-C18heteroaryl; R2, R3 and R4 are independently selected from a group consisting of H, halogen, CN, - NO2, SH, CF3, OH, CO2H, CONH2, OCF3, optionally substituted C1-C12alkyl, optionally substituted C1-C12haloalkyl optionally substituted C2-C12alkenyl, optionally substituted C2- C12alkynyl, optionally substituted C1-C12alkyloxy, optionally substituted C1- C12haloalkyloxy, optionally substituted C2-C12heteroalkyl, optionally substituted C3- C12cycloalkyl, optionally substituted C3-C12 cycloalkenyl, optionally substituted C2-C12 heterocycloalkyl, optionally substituted C2-C12 heterocycloalkenyl, optionally substituted C6- C18aryl, and optionally substituted C1-C18heteroaryl; R5 is selected H, optionally substituted C1-C12alkyl, optionally substituted C2- C12alkenyl, optionally substituted optionally substituted C1-C12 haloalkyl, optionally substituted C3-C12cycloalkyl, optionally substituted C6- C18aryl, and optionally substituted C1- Ci18heteroaryl; or a pharmaceutically acceptable salt, N-oxide, or prodrug thereof.
    具有拓扑异构酶抑制作用的Formula(1)化合物包括[在此插入公式]其中,R1从以下组中选择:H,OR5,可选择取代的C1-C12烷基,卤代烷基,C2-C12烯基,C2-C12炔基,C1-C12烷氧基,C1-C12卤代烷氧基,C2-C10杂基烷基,C3-C12环烷基,C3-C12环烯基,C2-C12杂环烷基,C2-C2杂环烯基,C6-C18芳基和C1-C18杂芳基;R2、R3和R4分别从以下组中选择:H,卤素,CN,-NO2,SH,CF3,OH,CO2H,CONH2,OCF3,可选择取代的C1-C12烷基,可选择取代的C1-C12卤代烷基,可选择取代的C2-C12烯基,可选择取代的C2-C12炔基,可选择取代的C1-C12烷氧基,可选择取代的C1-C12卤代烷氧基,可选择取代的C2-C12杂基烷基,可选择取代的C3-C12环烷基,可选择取代的C3-C12环烯基,可选择取代的C2-C12杂环烷基,可选择取代的C2-C12杂环烯基,可选择取代的C6-C18芳基,可选择取代的C1-C18杂芳基;R5选择为H,可选择取代的C1-C12烷基,可选择取代的C2-C12烯基,可选择取代的可选择取代的C1-C12卤代烷基,可选择取代的C3-C12环烷基,可选择取代的C6-C18芳基,可选择取代的C1-Ci18杂芳基;或其药学上可接受的盐、N-氧化物或前药。
  • NUCLEAR RECEPTOR MODULATORS AND THEIR USE FOR THE TREATMENT AND PREVENTION OF CANCER
    申请人:Neckers Jane B.
    公开号:US20140171503A1
    公开(公告)日:2014-06-19
    Disclosed are compounds which are nuclear receptor modulators that can act as antagonists to the androgen receptor, for example, a compound of Formula I: wherein R 1 to R 5 and X 1 to X 5 are as described herein, as well as pharmaceutically acceptable salts, solvates, and stereoisomers thereof. Pharmaceutical compositions comprising such compounds, as well as methods of use, and treatment for cancers, including prostate cancers, other nuclear receptor mediated cancers, and other conditions, are also disclosed.
  • Study of the Chemoselectivity of Grignard Reagent Addition to Substrates Containing Both Nitrile and Weinreb Amide Functionalities
    作者:Kommidi Harikrishna、Ananya Rakshit、Indrapal Singh Aidhen
    DOI:10.1002/ejoc.201300622
    日期:2013.8
    Several substrates containing both cyano and Weinreb amide functionalities have been synthesized to study the chemoselectivity of their reactions with organomagnesium bromides (ArMgBr and RMgBr). Excellent chemoselectivity towards the Weinreb amide was observed in most cases, even in the presence of excess Grignard reagent, affording cyano ketones in good-to-excellent yields.
    已经合成了几种含有氰基和 Weinreb 酰胺官能团的底物,以研究它们与有机溴化镁(ArMgBr 和 RMgBr)反应的化学选择性。在大多数情况下观察到对 Weinreb 酰胺的优异化学选择性,即使在过量格氏试剂存在的情况下,也能以良好到优异的产率提供氰基酮。
  • WAGNER G.; VOIGT B., PHARMAZIE <PHAR-AT>, 1976, 31, NO 8, 528-532
    作者:WAGNER G.、 VOIGT B.
    DOI:——
    日期:——
查看更多